Syndicated research at AplusA delivers real-world data insights on a macro or micro level depending on your research needs. Our expertise in segmenting and sub-segmenting healthcare markets allows us to obtain deep, unique data sets and navigate the intricacies of specific markets.

 

Background Information: Atopic Dermatitis

Eczema is an umbrella term for a group of autoimmune diseases that affect the skin. The most common and chronic form of eczema, also known as atopic dermatitis, also referred to as atopic eczema, typically causes patches of dry, itchy skin that may worsen and erupt into a rash when scratched.

Atopic dermatitis (AD) is a chronic inflammatory skin disease posing a significant burden on health-care resources and patients' quality of life. It is a complex disease with a wide spectrum of clinical presentations and combinations of symptoms. Onset of disease is most common by 5 years of age, and early diagnosis and treatment are essential to avoid complications of AD and improve quality of life. AD commonly resolves by the time a child reaches adulthood; however, approximately 10% to 30% of patients will continue to have symptoms of disease.

 

Objectives of Syndicated Study

To capture real world patient data in AD management particularly relating to moderate - servere AD among pediatrich and adult population:

  • Detailed patient profile (symptoms, location, severity, etc.)
  • Patient profile by line, context (initiation, switch, renewal) and drugs
  • Diagnosis and referral process
  • Brand penetration and shares by line, by AD patient segment
  • Detailed treatment pattern
  • Planned treatment durations
  • Therapy switches
  • Patient request/role in drug choice
  • Impact of new product launches

 

Overview of Research Topics

Utilizing PRFs and physician surveys the study covers the following topics:

  • Patient and disease specifics including demographics and comorbidities
  • Diagnosis and current symptoms
  • Treatment specifics
  • Physician adoption ladder
  • Beliefs and attitudes (including towards biologic therapy) in AD treatment

 

Benefits of Syndicated Study

  • Syndicated data-research helps to avoid over-researching respondents
  • PRF filled in by physicians 
  • 2 waves of the study per year 
  • Online interviews with physicians: cost-effective and fast turnaround
  • Regional spread of physicians across countries 
  • Robust sample sizes per country

 

Planning

 

                                                                                                                                                          

 Wave 1 - Q2 2020                                                               Wave 2 - 2020                                      Frequency Flexible

 

                                                             

                                                                                                                   

 

Contact us